期刊文献+

甲状腺结节伴乳头状癌临床特征及恶性风险因素分析 被引量:13

Clinical characteristics and risk factors of papillary thyroid carcinoma in patients with thyroid nodules
原文传递
导出
摘要 目的探讨甲状腺结节伴乳头状癌(papillary thyroid cancinoma,PTC)的临床特征和危险征象。方法 409例首次行甲状腺结节手术患者,经组织病理确诊PTC 175例(PTC组),甲状腺良性结节234例(良性组),回顾性分析2组临床资料,比较甲状腺超声及甲状腺血清学特点,logistic回归分析PTC的独立危险征象。结果 PTC组中位年龄(44岁)低于良性组(51岁)(P〈0.01);甲状腺超声显示PTC组2个结节(17.7%)、实性结节(61.7%)、结节直径≤2cm(72.6%)、低回声(61.7%)、边界不清(43.4%)、形态不规则(59.4%)及微小钙化率(62.8%)高于良性组(8.1%、50.4%、42.3%、41.5%、17.9%、18.8%、22.2%)(P〈0.05);PTC组抗甲状腺球蛋白抗体(3.6(0.0,596.0)u/mL)高于良性组(3.0(0.0,423.0)u/mL)(P〈0.05);年龄≤40岁(OR=0.969,95%CI:0.951~0.987,P=0.001)、结节形态不规则(OR=4.176,95%CI:2.572~6.780,P=0.000)、微小钙化(OR=2.487,95%CI:1.528~4.049,P=0.000)、结节数目(OR=1.403,95%CI:1.035~1.901,P=0.029)及结节直径(OR=0.702,95%CI:0.579~0.852,P=0.000)是PTC的独立危险征象。结论 PTC好发于40岁以下患者,超声声像中结节形态不规则、微小钙化、结节直径有助于术前判断PTC。 Objective To explore the clinical characteristics and risk factors of papillary thyroid carcinoma(PTC)in patients with thyroid nodules.Methods A total of 409 patients with thyroid nodules undergoing first thyroidectomy included 175 patients with pathologically confirmed PTC(PTC group)and 234 patients with benign thyroid nodules(control group).The clinical data were retrospectively analyzed to compare sonographic imagings and laboratory results between two groups.The independent risk factors of PTC were studied by logistic regression analysis.Results The median age was lower in PTC group(44 years old)than that in control group(51 years old)(P〈0.01).The rates of sonographic images of two nodules(17.7%),solid nodule(61.7%),nodular diameter≤2cm(72.6%),low-level echo(61.7%),blurred margin(43.4%),irregular shape(59.4%)and microcalcification(62.8%)were higher in PTC group than those in control group(8.1%,50.4%,42.3%,41.5%,17.9%,18.8%,22.2%)(P〈0.05).The level of antithyroglobulin antibodies in PTC group(3.6(0.0,596.0)u/mL)was higher than that in control group(3.0(0.0,423.0)u/mL)(P〈0.05).The age ≤40years(OR=0.969,95% CI:0.951 to 0.987,P=0.001),irregular shape(OR=4.176,95%CI:2.572 to 6.780,P=0.000),microcalcification(OR=2.487,95%CI:1.528 to 4.049,P=0.000),nodule number(OR=1.403,95% CI:1.035 to 1.901,P=0.029)and nodular diameter(OR=0.702,95%CI:0.579 to 0.852,P=0.000)were independent risk factors of PTC.Conclusion PTC often occurs in those under 40 years old.Sonographic finding contributes to its preoperative diagnosis.
出处 《中华实用诊断与治疗杂志》 2015年第1期53-55,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 北京市卫生系统高层次卫生技术人才项目(2013-2-006)
关键词 乳头状癌 甲状腺结节 恶性特征 Papillary thyroid carcinoma thyroid nodule clinical malignant characteristics
  • 相关文献

参考文献9

  • 1张惠,王春雷,王旺河,余广增,张秋丽.结节性甲状腺肿合并甲状腺癌的诊治分析[J].中华实用诊断与治疗杂志,2009,23(12):1241-1242. 被引量:5
  • 2Rossi M, Buratto M, Bruni S, et al. Role of ultrasonographic/clinical profile, cytology, and BRAFV600E mutation evaluationin thyroid nodule screening for malignancy: a prospective study[J]. J Clin Endocrinol Metab,2012,97(7) : 2354-2361.
  • 3郭艳,潘如凤,宋伟,徐园园,吕宏安.彩色多普勒超声对甲状腺癌诊断的临床应用价值[J].中华全科医学,2013,11(9):1454-1455. 被引量:32
  • 4于璐,尚敬.462例甲状腺结节临床分析[J].中华实用诊断与治疗杂志,2011,25(11):1124-1125. 被引量:7
  • 5Wang Z,Zhang H, Zhang P, et al. Diagnostic value ofultrasound-detected calcification in thyroid nodules [J]. AnnAcad Med Singapore,2014,43(2) : 102-106.
  • 6张晓玲,刘桂华,郑继伟.彩超在甲状腺癌诊断中的应用价值[J].临床医学,2010,30(7):113-114. 被引量:3
  • 7Smith-Bindman R, Lebda P,Feldstein VA, et al. Risk ofthyroid cancer based on thyroid ultrasound imagingcharacteristics: results of a population-based study [J]. JAMAIntern Med, 2013,173(19) : 1788-1795.
  • 8Jankovic B, LeKT,Hershman JM. Hashimoto's thyroiditis andpapillary thyroid carcinoma: is there a correlation? [J]. J ClinEndocrinol Metab,2013,98(2) :474-484.
  • 9Negro R, Valcavi R, Toulis KA. Incidental thyroid cancer intoxic and nontoxic goiter: is TSH associated with malignancyrate? Results of a meta-analysis[J]. Endocr Pract, 2013,19(2):212-218.

二级参考文献32

共引文献43

同被引文献102

  • 1危常鹏.手术联合131I、甲状腺片治疗甲状腺乳头状癌疗效观察[J].医学信息,2017,30(12):53-54. 被引量:3
  • 2王建红,王正滨,房世保,李萍,孙咏梅,禹静,杨雪,牛晓燕.桥本甲状腺炎合并多灶性甲状腺乳头状癌的超声诊断价值[J].中华医学超声杂志(电子版),2013,10(7):596-598. 被引量:14
  • 3Syrenicz A,Koziolek M,Ciechanowicz A,et al.New insights into the diagnosis of nodular goiter[J].Thyroid Res, 2014,7 : 6.
  • 4Gharib H, Papini E, Paschke R, et al.American association of clinical endocrinologists,associazione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules : executive summary of recommendations [J].J Endocrinol Invest, 2010,33 (5 Suppl) : 51-56.
  • 5Azizi G,Malchoff CD.Autoimmune thyroid disease:a risk factor for thyroid cancer[J].Endocr Pract,2011,17 (2) : 201 - 209.
  • 6Nachiappan AC ,Metwalli ZA, Hailey BS,et al.The thyroid: review of imaging features and biopsy techniques with ra- diologie -pathologic correlation [J].Radiographics, 2014,34 (2):276-293.
  • 7Wiersinga WM.Management of thyroid nodules in children and adolescents[J].Hormones (Athens) ,2007,6 (3) : 194- 199.
  • 8Osipoff JN,Wilson TA.Consultation with the specialist: thyroid nodules[J].Pediatr Rev, 2012,33 (2) : 75-81.
  • 9Bas VN,Aycan Z,Cetinkaya S,et al.Thyroid nodules in chil- dren and adolescents:a single institution's experience[J].J Pediatr Endocrinol Metab, 2012,25 (7-8) : 633-638.
  • 10Rago T,Fiore E,Scutari M,et al.Male sex,single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease[J]. Eur J Endocrinol,2010, 162(4) :763-770.

引证文献13

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部